Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
08:00am, Thursday, 07'th Jan 2021
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2020 financial results on Thursday, February 11, 2021 after the close o
Seagen Earns Top Honors from Key Biotech Publication
10:25am, Thursday, 31'st Dec 2020
Seagen, Inc. (SGEN) has recently been named Biotech of the Year by leading industry publication Biopharma Dive, and investors would no doubt agree. Shares of the Seattle-area firm are up nearly 65% ye
Seagen to Present at the J.P. Morgan Healthcare Conference
08:00am, Wednesday, 16'th Dec 2020
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:0
7 Biotech Stocks To Buy Beyond Covid Vaccine Plays
01:37pm, Monday, 14'th Dec 2020
It's a relief to know Covid-19 vaccines are on the way. But there are plenty of other great biotechs that have been overlooked in the market frenzy.
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion re
Seagen Highlights TUKYSA® (tucatinib) Data in Breast Cancer at Virtual 2020 San Antonio Breast Cancer Symposium
08:00am, Tuesday, 08'th Dec 2020
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced the presentation of new data from TUKYSA (tucatinib), its HER2-positive metastatic breast cancer therapy, at the San Antonio
Seagen Announces Multiple ADCETRIS® (brentuximab vedotin) Presentations at the 2020 ASH Annual Meeting
10:00am, Monday, 07'th Dec 2020
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced multiple ADCETRIS® (brentuximab vedotin) data presentations at the 62nd American Society of Hematology (ASH) Annual Meeting
3 Top Growth Stocks to Buy on the Dip
06:31am, Saturday, 14'th Nov 2020
All of these stocks are down more than 10% in the past four weeks.
Seagen Inc. Has Struck Gold; Value For Shareholders + 30% Upside
10:25pm, Sunday, 01'st Nov 2020
Seagen have struck gold with its Merck deal, which sees billions in value creation with long-tailed asset returns. Its antibody-drug conjugate segment has seen label expansion into several key oncolog
Why Seagen Shares Are Tumbling 12.5% Today
12:43pm, Friday, 30'th Oct 2020
A broad market sell-off is trumping third-quarter results that outpaced analyst expectations.
Seagen's (SGEN) CEO Clay Siegall on Q3 2020 Results - Earnings Call Transcript
12:26am, Friday, 30'th Oct 2020
Seagen's (SGEN) CEO Clay Siegall on Q3 2020 Results - Earnings Call Transcript
7 Strong Nasdaq Stocks to Buy As They Keep Marching Higher
12:08am, Monday, 26'th Oct 2020
Most Nasdaq stocks have seen ups and downs this year. But these seven have weathered the pandemic well and are bound to climb higher soon.
